Public-registry site landscape for NCT03315182, a Mucopolysaccharidosis Type 3 B study sponsored by Abeona Therapeutics, Inc. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT03315182 (registry record) |
| Sponsor | Abeona Therapeutics, Inc |
| Condition(s) | Mucopolysaccharidosis Type 3 B |
| Phase | PHASE1 / PHASE2 |
| Listed sites | 4 |
| Site countries | United States, France, Germany, Spain |
Eichor generates a preliminary site-risk snapshot for NCT03315182 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →